Company · CIK 0001213037 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Cardiff Oncology, Inc. · CRDF
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 14, 2026 PForm 4 → | Jul 16, 4:03 pm EDT | Gary W PaceDirector | 687,285 | $1.46 | $1,000,000 | 2,043,661 | +50.7% | |
| Jul 14, 2026 PForm 4 → | Jul 16, 4:01 pm EDT | Mani MohindruChief Executive Officer, Director | 34,364 | $1.46 | $50,000 | 59,067 | +139% | |
| Jun 18, 2026 PForm 4 → | Jun 22, 9:00 am EDT | Mani MohindruChief Executive Officer, Director | 24,703 | $1.21 | $29,891 | 24,703 | — | |
| Jun 18, 2026 PForm 4 → | Jun 22, 9:00 am EDT | Gary W PaceDirector | 30,000 | $1.22 | $36,600 | 1,356,376 | +2.26% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 14, 2026 PForm 4 → | Jul 16, 4:03 pm EDT | Gary W PaceDirector | 687,285 | — | — | 687,285 | — | |
| Jul 14, 2026 PForm 4 → | Jul 16, 4:01 pm EDT | Mani MohindruChief Executive Officer, Director | 34,364 | — | — | 34,364 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 9:30 pm EDT | James O ArmitageDirector | 40,565 | — | — | 228,104 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 9:30 pm EDT | Lale WhiteDirector | 40,565 | — | — | 199,246 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 9:30 pm EDT | Renee P TannenbaumDirector | 40,565 | — | — | 209,331 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 9:30 pm EDT | Rodney S MarkinDirector | 40,565 | — | — | 263,430 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 9:30 pm EDT | Gary W PaceDirector | 40,565 | — | — | 228,104 | — |